A dose-response study with strontium malonate in postmenopausal women. A 12 week, multi national, double blind, randomized, 5 arms, parallel group placebo controlled open label active controlled, phase II study with 3 dose levels of strontium malonate and Protelos within post menopausal women with a BMDT-score below -1

Trial Profile

A dose-response study with strontium malonate in postmenopausal women. A 12 week, multi national, double blind, randomized, 5 arms, parallel group placebo controlled open label active controlled, phase II study with 3 dose levels of strontium malonate and Protelos within post menopausal women with a BMDT-score below -1

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Strontium malonate; Strontium ranelate
  • Indications Bone resorption; Menopause; Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Acronyms STRONG
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 11 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top